Varex Imaging Corporation
VREXHealthcareNASDAQMedical Devices · Last scanned May 30, 2026
Scan Results
Daily timeframeVarex Imaging Corporation designs, manufactures, and sells X-ray imaging components. With a market capitalization of $431.2M, it sits in small-cap territory. It operates through two segments, Medical and Industrial.
Market Cap
$431.2M
Beta
0.96
P/E (TTM)
—
P/E (Fwd)
9.58
EPS (TTM)
$-2.00
EPS (Fwd)
$1.07
ROE
-15.7%
ROA
3.2%
Cash
$88.3M
Total Debt
$381.0M
Free CF
-$40.3M
52W Change
33.6%
Annual Financials
Cash vs Debt
Varex Imaging Corporation carries $381.0M in total debt against $88.3M in cash reserves — debt is roughly 4.3x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow is running at -$40.3M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -15.7% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.2% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $859.4M (2022) to $844.6M (2025).
Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Varex Imaging Corporation's trajectory.